Erik Welf

Critic
DISC Type : C

Director, Head of Integrative Systems Biology at Orion Pharma

New York City Metropolitan Area, United States

Overview

Erik Welf serves as the Director and Head of Integrative Systems Biology at Orion Pharma. Leveraging his PhD from the University of Delaware, he specializes in experimental biology and quantitative pharmacology, designing strategies to move drug assets from ideation to approval more efficiently.

His research has uncovered that the "blebs" on highly metastatic cancer cells are not just for movement but also function as critical signaling hubs that promote cell survival.

Personality Overview

Information Seeker

Precise

Objective Thinker

They like to do things independently and don’t look for support from others.  Unless the value is proven by data, they are unlikely to value fancy features. It is very likely that they will negotiate pricing or other important terms.

Topics They Care About

Quantitative Pharmacology
He applies quantitative systems pharmacology (QSP) and systems biology to drive preclinical and clinical decision-making in innovative medicines.
Oncology Drug Development
His career includes providing creative modeling solutions for oncology at Regeneron and managing a team researching cancer biology at UT Southwestern Medical Center.
Efficient Drug Development
A core part of his professional philosophy is to design Model-Informed Drug Development (MIDD) strategies to move assets faster through the pipeline.

Media Appearances

Erik has no verified media appearances

Work History

10-2024
Director, Head of Integrative Systems Biology at Orion Pharma
1-2024 - 9-2024
Principal Quantitative Systems Pharmacologist at Regeneron
6-2021 - 1-2024
Quantitative Pharmacologist at Regeneron
1-2012 - 6-2021
Research Faculty at UT Southwestern Medical Center
3-2009 - 12-2012
Quantitative Systems Pharmacology (Post Doc) at North Carolina State University

Education

2003 - 2009
PhD from University of Delaware
1998 - 2002
BS from North Carolina State University

More Information

Social Presence :

Prographics :

Exp : 16 Location : New York City Metropolitan Area, United States Job Level : Mid-senior Designation : Director, Head of Integrative Systems Biology at Orion Pharma
URL has been copied!

Insights For Selling To Erik

During A Call Or A Meeting

DO's

  • Be formal and objective, they will appreciate it more
  • Be ready to answer many clarity-seeking questions and requests for information
  • Tell them what ROI they can expect

DONT's

  • Do not use very emotional or colorful language
  • Don't give superficial answers, they are easily rattled by them
  • Avoid pushing them too much to involve other stakeholders unless it is critical

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Erik is

  • Proven ROI, pricing and objective proof points are the factors that sway their decision.
  • Will you ever get a clear answer from Erik

  • They are comfortable saying no if they are convinced that it is the correct decision.

Insights For Deal Planning

    How fast (or slow) will Erik move?

  • Their decision-making is neither very fast nor very slow, they are somewhere in between.
  • Can Erik take some risk or not?

  • They can take risks if their analysis shows that it would be worth it.

You And Erik

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.